The potential role of catheter-based renal sympathetic denervation in chronic and end-stage kidney disease

Markus P. Schlaich, Yusuke Sata

Research output: Chapter in Book/Conference paperChapter

Abstract

The introduction of catheter-based radiofrequency renal sympathetic denervation to clinical medicine has been considered to be a promising new avenue to the future device-based therapy of hypertension. Renal sympathetic efferent and afferent nerves located in the adventitia of the renal artery are the target of this procedure. On the basis of their crucial role in development and maintenance of systemic hypertension, renal sympathetic nerves have long been considered to be an attractive target for neuromodulation therapy [1].

Original languageEnglish
Title of host publicationRenal Denervation
Subtitle of host publicationA New Approach to Treatment of Resistant Hypertension
PublisherSpringer-Verlag London Ltd.
Pages181-189
Number of pages9
ISBN (Electronic)9781447152231
ISBN (Print)9781447152224
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint Dive into the research topics of 'The potential role of catheter-based renal sympathetic denervation in chronic and end-stage kidney disease'. Together they form a unique fingerprint.

  • Cite this

    Schlaich, M. P., & Sata, Y. (2015). The potential role of catheter-based renal sympathetic denervation in chronic and end-stage kidney disease. In Renal Denervation: A New Approach to Treatment of Resistant Hypertension (pp. 181-189). Springer-Verlag London Ltd.. https://doi.org/10.1007/978-1-4471-5223-1_22